Massachusetts Institute of Technology
Area of Study
1986 - 1990
Scott Rakestraw is president and managing director of The Branta Group LLC, a healthcare company formation, capital investment, and strategic advisory firm. Over the past 15 years, The Branta Group LLC and its family of companies have been instrumental in 11 successful IPOs, the development and registration of several new biopharmaceutical medicines, and the acquisition of multiple biopharmaceutical companies. He currently serves on the board of directors of Sojournix, Inc, an asset-focused biopharmaceutical company that he co-founded in 2016. Dr. Rakestraw received his bachelor’s of science from the University of Illinois, and as a Hertz Fellow, his PhD in chemical engineering from MIT.
1990 - Monoclonal Antibody-Targeted Laser Photolysis of Tumor Tissue